Strategic workshop on decentralized clinical trials
This week our colleagues from ABF were our guests in our facility in northern Germany.
Together with our partner AMEDON GmbH we prepared for the future with a strategic workshop on decentralized clinical trials. There are a lot of challenges and risks for pharmaceutical companies launching decentralized trials. Compliance and data integrity are important issues in data collection.
The GBA Group is a unique service provider for the international pharmaceutical and biotech industry. The well-known companies Pharmacelsus, ABF Pharmaceutical Services, LKF Central Laboratory and GBA Pharma Labs operate under the Pharma sector.
AMEDON is specialized in developing and delivering web-based solutions for clinical research.
Dr. Gerrit Schoenicke (Managing Director of LKF): "Tracking data and ensuring compliance on a global scale are essential for the success of decentralized clinical trials. Together with ABF and Amedon we can offer the appropriate solution."
Dr. Andreas Nechansky, QP (Managing Director of ABF): "We support clients with our worldwide GMP depots, EU GMP manufacturing site for labelling and packaging and QP services. Integrating new technologies is one key feature for data tracking and integrity."
Bernard Brandewiede (Managing Director AMEDON): "Discussions with our partners from LKF and ABF always result in some great ideas to make the life of our clients easier. It was a pleasure to meet them at the LKF facility in northern Germany.”
We know every project is unique and every project has specific requirements. Together with the customer we find the best solution. Our tailored solutions and central laboratory services help you to optimize processes and ensure the validity and integrity of all laboratory data and processes.